Dementia and testosterone levels in men [2] (multiple letters)

JAMA

Volumn 293, Issue 5, 2005, Pages 551-552

  Daniell, Harry W ^a   Bowen, Richard L ^b   Martins, Ralph N ^c   Gregory, Christopher W ^b   Smith, Mark A ^d   Atwood, Craig S ^d   Pike, Christian J ^e   Rosario, Emily R ^f   Stanczyk, Frank Z ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Voyager Pharmaceutical Corporation   (United States)

^c HOLLYWOOD PRIVATE HOSPITAL   (Australia)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f Neuroscience Graduate Program

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA AMYLASE; ESTRADIOL; FOLLISTATIN; FOLLITROPIN; GONADORELIN; INHIBIN; LUTEINIZING HORMONE; OPIATE; SEX HORMONE; TESTOSTERONE; NARCOTIC AGENT;

ALZHEIMER DISEASE; ANDROGEN DEFICIENCY; BODY MASS; CASTRATION; DEATH; DEMENTIA; ENZYME BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; LETTER; NONHUMAN; OBESITY; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; ANIMAL; MALE; METABOLISM; NOTE;

ALZHEIMER DISEASE; ANIMALS; HUMANS; LUTEINIZING HORMONE; MALE; TESTOSTERONE; NARCOTICS;

EID: 12844256480     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.293.5.552-a     Document Type: Letter

References (0)